Answers are grounded in this paper and cite their sources.
In vitro experiment reveals effective urease inhibition by nickel and copper Schiff base complexes, highlighting potential therapeutic applications.
Three new trinuclear complexes containing either nickel(II), copper(II) or zinc(II), [Ni3L2(NO3)2(CH3OH)2]·2CH3OH (1), [Cu3Br2L2] (2), [Zn3L2(NCS)2(CH3OH)2]·0.5CH3OH·0.5H2O (3), and a new dioxidomolybdenum(VI) complex, [MoO2L] (4), have been prepared from the bis-Schiff base N,N'-bis(4-bromosalicylidene)-1,3-propanediamine (H2L) with various metal salts in methanol. The complexes were characterized by elemental analysis, IR and UV–Vis spectra. Molecular structures were confirmed by single crystal X-ray diffraction experiments. The Ni ions in 1 adopt an octahedral coordination environment, bridged by phenolate oxygen and nitrate ligands. The Cu ions in 2 are square pyramidal and square planar, and the Zn ions in 3 are square pyramidal and octahedral. The metal atoms in 2 and 3 are bridged by phenolate oxygen donors. The Mo ion in 4 is octahedral. The Schiff base ligand coordinates to the metal atoms through two phenolate O and two imino N donors. Biological assays revealed that the nickel and copper complexes have effective urease inhibition.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: